• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Ethereum On-Chain Activity Surges

chest

The Ethereum ecosystem has seen a historic increase in on-chain activity, marking a significant milestone for the network.

user avatarKaterina Papadopoulou

Solana Price Approaches Key Fibonacci Zone Amid Analyst Optimism

chest

Market analyst Crypto Patel highlights Solana's potential for a price breakout as it reenters a historically significant Fibonacci zone.

user avatarMaya Lundqvist

Bitcoin Enters DCA Zone Amid Market Uncertainty

chest

Bitcoin's price has entered a dollar-cost averaging (DCA) zone, indicating potential accumulation opportunities as market sentiment declines.

user avatarLi Weicheng

Mixed Signals in Dogecoin Network Activity

chest

Recent analysis indicates mixed signals in Dogecoin's network activity, with an increase in active addresses and transaction counts, but a decline in overall market strength.

user avatarAisha Farooq

Dogecoin Exchange Reserves Show Slight Decline

chest

Dogecoin exchange reserves have decreased by 0.20% in the last day and 0.60% in the last week, indicating a potential shift in market dynamics.

user avatarBayarjavkhlan Ganbaatar

Dogecoin Enters Depressed Valuation Zone

chest

Dogecoin has entered a deeply depressed onchain valuation zone, trading significantly below its realized price, indicating potential capitulation among holders.

user avatarTenzin Dorje

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.